1755P Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial. - Laurence, V.; Cordero, C.; Dureau, S.; Jehanno, N.; Pierron, G.; Gaspar, N.; Valentin, T.; Revon-Riviere, G.; Lervat, C.; Taque, S.; Entz-Werle, N.; Mansuy, L.; et al. (Annals of Oncology, 2024)